{
    "clinical_study": {
        "@rank": "30117", 
        "arm_group": {
            "arm_group_label": "Hematooncology patients", 
            "description": "No intervention"
        }, 
        "biospec_descr": {
            "textblock": "Plasma specimens are kept frozen."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This is a prospective observational clinical study to characterise abnormalities of\n      thromboelastography (TEG) parameters in patients with chemotherapy-induced thrombocytopenia.\n      The investigators are also studying the influence of cytokines on bleeding and of\n      HLA-antibodies on effect of platelet transfusion in the patient group mentioned.\n\n      The investigators' hypothesis is that changes in TEG-parameters reflect the patients\n      tendency to bleed."
        }, 
        "brief_title": "Thromboelastography, Cytokines and HLA-antibodies in Patients With Chemotherapy-induced Thrombocytopenia", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bone Marrow Diseases", 
            "Lymphoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bone Marrow Diseases", 
                "Lymphoma", 
                "Thrombocytopenia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients are eligible for this study if:\n\n          -  They have chemotherapy-induced thrombocytopenia\n\n          -  They are in need of at least one platelet transfusion\n\n          -  They are aged 16 years or over\n\n          -  They consent to participate\n\n        Exclusion Criteria:\n\n        Patients are not eligible for this study if:\n\n          -  They have a known congenital clotting disorder\n\n          -  They need anticoagulants regularly in the study period\n\n          -  They have immune thrombocytopenic purpura"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hospital inpatients admitted to the Department of Medicine, Section for Haematology at\n        Haukeland University Hospital will be invited to join the study if they meet the inclusion\n        criteria."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928017", 
            "org_study_id": "2011/1881"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 20, 2013", 
        "location": {
            "contact": {
                "email": "elin.opheim@k2.uib.no", 
                "last_name": "Elin N Opheim, cand.med", 
                "phone": "004755973044"
            }, 
            "contact_backup": {
                "email": "torunn.oveland.apelseth@helse-bergen.no", 
                "last_name": "Torunn O Apelseth, dr. med", 
                "phone": "004755973092"
            }, 
            "facility": {
                "address": {
                    "city": "Bergen", 
                    "country": "Norway", 
                    "zip": "5021"
                }, 
                "name": "Haukeland University Hospital"
            }, 
            "investigator": {
                "last_name": "Elin N Opheim, cand.med", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_groups": "1", 
        "official_title": "Thromboelastography, Cytokines and HLA-antibodies in Patients With Chemotherapy-induced Thrombocytopenia", 
        "other_outcome": [
            {
                "description": "To investigate cytokine profiles in patients with and without bleeding with the aim of identifying risk factors of bleeding in patients with chemotherapy-induced thrombocytopenia", 
                "measure": "Cytokines", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "To investigate the relationship between TEG-parameters, bleeding and need for platelet transfusion.\nTo investigate the influence of HLA antibodies on risk of bleeding and transfusion complications.", 
                "measure": "Bleeding", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "overall_contact": {
            "email": "elin.opheim@k2.uib.no", 
            "last_name": "Elin N Opheim, cand.med.", 
            "phone": "004755973044"
        }, 
        "overall_contact_backup": {
            "email": "tor.hervig@helse-bergen.no", 
            "last_name": "Tor A Hervig, dr.med", 
            "phone": "004755972492"
        }, 
        "overall_official": {
            "affiliation": "University of Bergen", 
            "last_name": "Tor A Hervig, dr.med", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway: Regional Ethics Commitee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To characterise changes in TEG-parameters in patients with chemotherapy-induced thrombocytopenia", 
            "measure": "Thromboelastography", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928017"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Bergen", 
            "investigator_full_name": "Elin Netland Opheim", 
            "investigator_title": "Research fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Bergen", 
        "sponsors": {
            "collaborator": {
                "agency": "Haukeland University Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Bergen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}